News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
496,416 Results
Type
Article (32857)
Company Profile (89)
Press Release (463465)
Multimedia
Podcasts (129)
Webinars (15)
Section
Business (160266)
Career Advice (1247)
Deals (24728)
Drug Delivery (151)
Drug Development (58896)
Employer Resources (107)
FDA (11014)
Job Trends (10821)
News (241013)
Policy (24756)
Tag
2025 Best Places to Work (9)
2026 Best Places to Work (16)
2027 BioCapital Standard (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
40 Under 40 (2)
Academia (2232)
Academic (1)
Accelerated approval (58)
ADA (34)
Adcomms (24)
Allergies (164)
Alliances (37387)
ALS (178)
Alzheimer's disease (1310)
Antibody-drug conjugate (ADC) (489)
Approvals (11647)
Artificial intelligence (595)
ASCO (223)
Autoimmune disease (278)
Automation (45)
Bankruptcy (227)
Belgium (25)
Best Places to Work (8185)
BIO (52)
Biologics (78)
BIOSECURE Act (21)
Biosimilars (252)
BioSpace Insights (124)
Biotechnology (47)
Bispecific (39)
Bladder cancer (127)
Brain cancer (68)
Breast cancer (596)
Cancer (4846)
Cardiovascular disease (446)
Career advice (1088)
Career pathing (33)
CAR-T (225)
CDC (60)
CDMO (150)
Celiac Disease (4)
Cell therapy (600)
Cervical cancer (55)
Clinical research (52884)
Collaboration (1803)
Commercialization (51)
Company closure (4)
Compensation (568)
Complete response letters (72)
COVID-19 (2251)
CRISPR (96)
CRO (5)
C-suite (1182)
Cystic fibrosis (124)
Data (6913)
Decentralized trials (3)
Denatured (33)
Depression (142)
Dermatology (131)
Diabetes (489)
Diagnostics (4323)
Digital health (50)
Diversity (8)
Diversity, equity & inclusion (32)
Drug discovery (305)
Drug pricing (192)
Drug shortages (32)
Duchenne muscular dystrophy (206)
Earnings (53137)
Editorial (54)
Employer branding (10)
Employer resources (99)
ESMO (278)
Events (69993)
Executive appointments (987)
Eye disease (11)
FDA (14205)
Fibrodysplasia Ossificans Progressiva (15)
Fragile X (6)
Friedreich's ataxia (10)
Frontotemporal dementia (17)
Funding (1489)
Gene editing (175)
Generative AI (53)
Gene therapy (500)
GLP-1 (909)
Government (4041)
Grass and pollen (6)
Guidances (310)
Healthcare (12444)
Hematology (152)
HIV (90)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (8)
IgA nephropathy (114)
Immunology and inflammation (206)
Immuno-oncology (102)
Indications (213)
Infectious disease (2540)
Inflammatory bowel disease (171)
Inflation Reduction Act (11)
Influenza (94)
Intellectual property (236)
Interviews (210)
IPO (10074)
IRA (43)
Job creations (2848)
Job search strategy (926)
JPM (52)
Kidney cancer (25)
Kidney disease (127)
Labor market (82)
Layoffs (358)
Leadership (33)
Legal (5783)
Licensing (103)
Liver cancer (63)
Longevity (32)
Lung cancer (734)
Lung diease (18)
Lymphoma (362)
Machine learning (39)
Management (40)
Manufacturing (1081)
Marketing (30)
MASH (179)
Medical affairs (5)
Medical device (6523)
Medtech (6673)
Mergers & acquisitions (15657)
Metabolic disorders (1305)
Middle East (1)
mRNA (183)
Multiple sclerosis (179)
Multispecific (3)
NASH (21)
Netherlands (22)
Neurodegenerative disease (331)
Neuropsychiatric disorders (83)
Neuroscience (2611)
Neurotech (3)
NextGen: Class of 2026 (4662)
Non-profit (3838)
Now hiring (43)
Obesity (621)
Opinion (241)
Ovarian cancer (162)
Pain (251)
Pancreatic cancer (234)
Parkinson's disease (265)
Partnered (35)
Patents (480)
Patient advocacy (8)
Patient recruitment (545)
Patient selection (67)
Peanut (42)
People (47516)
Peptides (31)
Pharmaceutical (38)
Pharmacy benefit managers (33)
Phase 1 (14375)
Phase 2 (22985)
Phase 3 (19307)
Pipeline (9264)
Policy (314)
Postmarket research (1993)
Preclinical (5829)
Press Release (66)
Prostate cancer (275)
Psychedelics (66)
Radioligand (2)
Radiopharmaceuticals (274)
Rare diseases (1021)
Real estate (4478)
Recruiting (43)
Regenerative medicine (13)
Regulatory (19881)
Reports (52)
Research institute (2062)
Resumes & cover letters (168)
Rett syndrome (24)
RNA editing (19)
RSV (62)
Saudi Arabia (1)
Schizophrenia (160)
Series A (258)
Series B (162)
Service/supplier (3)
Sickle cell disease (100)
Special edition (19)
Spinal muscular atrophy (131)
Sponsored (32)
Startups (2685)
State (2)
Stem cells (5)
Stomach cancer (14)
Substance use disorders (16)
Supply chain (112)
Switzerland (16)
Tariffs (92)
Tax incentives (1)
The Weekly (94)
Vaccines (903)
Venture capital (117)
Weight loss (388)
Wet AMD (4)
Women's health (123)
Women in leadership (2)
Worklife (13)
Date
Today (136)
Last 7 days (555)
Last 30 days (2327)
Last 365 days (19404)
2026 (17619)
2025 (18744)
2024 (21718)
2023 (24959)
2022 (34151)
2021 (36999)
2020 (36604)
2019 (32969)
2018 (25231)
2017 (22802)
2016 (22610)
2015 (26570)
2014 (20595)
2013 (17279)
2012 (18562)
2011 (19349)
2010 (17189)
Location
Africa (628)
Alabama (43)
Alaska (5)
Arizona (244)
Arkansas (11)
Asia (38355)
Australia (4970)
California (8658)
Canada (3595)
China (1988)
Colorado (367)
Connecticut (337)
Delaware (320)
Europe (69812)
Florida (1570)
Georgia (306)
Hawaii (2)
Idaho (38)
Illinois (904)
India (136)
Indiana (527)
Iowa (7)
Japan (657)
Kansas (119)
Kentucky (50)
Louisiana (50)
Maine (17)
Maryland (1274)
Massachusetts (6303)
Michigan (218)
Minnesota (500)
Mississippi (5)
Missouri (114)
Montana (22)
Nebraska (19)
Nevada (116)
New Hampshire (40)
New Jersey (3097)
New Mexico (26)
New York (2688)
North Carolina (1276)
North Dakota (3)
Northern California (4352)
Ohio (303)
Oklahoma (17)
Oregon (27)
Pennsylvania (1895)
Puerto Rico (28)
Rhode Island (27)
South America (865)
South Carolina (40)
South Dakota (2)
Southern California (3679)
Tennessee (163)
Texas (1486)
United States (33364)
Utah (204)
Vermont (2)
Virginia (324)
Washington D.C. (61)
Washington State (708)
West Virginia (3)
Wisconsin (149)
Wyoming (6)
496,416 Results for "china national pharmaceutical group corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
New biotech group rises to fuel American rockets in China ‘space race’
Members of the American Biotech Innovation Alliance (ABIA) want to build a national biotech strategy—just like China did years ago.
June 10, 2026
·
3 min read
·
Annalee Armstrong
China
Without US action on China’s innovation blitz, biotech leaders see a Rust Belt future
Policy uncertainty is hampering the growth of U.S. biotech as China rises thanks to carefully planned investment in the industry, experts said during a
BioSpace
webinar.
November 11, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
NRDL+ Releases 2026 Mid-Year China Access Outlook as China Fine-Tunes Innovation Access Under Tighter Constraints
Executive strategic briefing examines how China’s evolving health policy, coverage, and financing environment is reshaping decisions across the medical technology lifecycle tags: #ChinaMarketAccess #LifeSciencesStrategy #PricingAndReimbursement #ChinaHealthPolicy #CommercialHealthInsurance
September 17, 2026
·
1 min read
China
6 potential blockbusters that could pave China’s path to 2030 ambitions
In its latest five-year plan, China has set its sights on developing five drugs that could each rake in more than $1 billion globally by 2030. Experts say it’s well on its way, with two medications having already met that bar.
November 4, 2026
·
8 min read
·
Tristan Manalac
Earnings
Pfizer, fresh to China’s obesity market, looks to Viagra model to compete
Pfizer is calling upon lessons learned from one of the first drugs ever made available on the internet—Viagra—as it commercializes a new obesity drug in China.
November 3, 2026
·
3 min read
·
Annalee Armstrong
Immunology and inflammation
Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStar
Gilead Sciences has picked up a new inflammatory disease program from China’s PepStar Therapeutics to pair with the Phase 2 inflammatory bowel disease asset emvistegrast.
October 23, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products
November 15, 2026
·
5 min read
Press Releases
Ascentage Pharma Announces Inclusion of Lisaftoclax in China’s 2026 National Reimbursement Drug List and Successful Renewal of Coverage for Olverembatinib
November 15, 2026
·
7 min read
Podcast
Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners
China cracks down on some biotechnology ownership transfers—but will the new policy impact licensing deals?; Disc Medicine’s Phase 3 data sweep redeems rejected rare disease therapy, teeing up another FDA run; and the ESMO conference gets underway in Madrid this week, with much-anticipated data from Merck, and Summit Therapeutics.
October 21, 2026
·
1 min read
·
Jef Akst
Deals
China’s Haisco forms immunology biotech with up to $1.5B from American VCs
Haisco Pharmaceutical Group has been on a deal hot streak this year, inking major deals with Eli Lilly, AbbVie and more. The new company will take on one of Haisco’s core immunology assets.
August 25, 2026
·
1 min read
·
Annalee Armstrong
1 of 49,642
Next